See what questions
a doctor would ask.
A study by a Chicago university showed that most men with prostate cancer undergoing androgen-deprivation therapy or hormone therapy did not have osteoporosis treatment or prevention. Hormone therapy in men undergoing hormone therapy treatment has previously been linked with an increased risk of osteoporosis. In the study group, only 14.7 received osteoporosis treatment, 8.7% were screened for osteoporosis and only 4.9% were prescribed bisphospohonate to prevent bone loss. It was found that primary care physicians were most likely to manage the osteoporosis risk and cancer specialists were the least likely. The risk factors for male osteoporosis include alcoholism, smoking, hormonal changes due to age, some medications and some prostate cancer treatment medications.
Source: summary of medical news story as reported by Yahoo - Health
About: Prostate cancer victims need more focus on osteoporosis prevention
Date: 13 December 2004
Source: Yahoo - Health
http:/ This summary article refers to the following medical categories:
Related Medical Topics
More News Topics
This summary article refers to the following medical categories:
Search Specialists by State and City